-
Sanofi India celebrates ‘DaanUtsav’
expressbpd
October 17, 2017
The company’s CSR team organised a series of activities where every employee was asked to spend four hours with children from vulnerable sections of society
-
More to be Done by Indian government to cope with rising sale of unapproved antibiotics
worldpharmanews
October 11, 2017
In India, the sale of antibiotics requiring the tightest control and regulation is rising the fastest, according to an analysis by researchers at Queen Mary University of London (QMUL) and Newcastle University.
-
Suven Life Science gets neuro patent from India, Japan
expressbpd
September 26, 2017
Drug firm Suven Life Sciences has been granted a patent each by India and Japan for a drug used in the treatment of neuro-degenerative diseases.
-
Agilent Technologies launches triple quadrupole mass spectrometer in India
expressbpd
September 25, 2017
Agilent Technologies has recently introduced the triple quadrupole liquid chromatography mass spectrometers (triple quad LC/MS) at the Analytica Anacon India.
-
Russia and India embark on the transfer of technologies of drugs production for treatment of HIV inf
expressbpd
September 21, 2017
Deal aimed at reducing cost of these medications in Russian market
-
Report identifies two-tier pharmaceuticals market
europeanpharmaceuticalreview
August 11, 2017
A report released has identified a two-tier manufacturing market and forecast increased acquisitions by Indian companies…
-
India’s pharmaceutical market set to hit $100bn by 2025
europeanpharmaceuticalreview
August 09, 2017
The future looks bright for India’s pharmaceutical environment says Vanaja Krishnan, Managing Director of George Clinical, India
-
India has recognised the need for strong innovation policies
expressbpd
August 07, 2017
Recently, World Bank has announced its new project ‘Innovate in India for Inclusiveness’, to help India develop an innovative biopharmaceutical and medical devices industry and promote industry-academia dialogues. Jorge A Coarasa, Senior Economist (Health
-
India set to block $1.3 bn Gland Pharma-Fosun deal : Report
expressbpd
August 02, 2017
The deal was announced last July when Shanghai Fosun agreed to buy an 86 per cent stake in KKR & Co-backed Gland Pharma
-
Resurgence of swine flu in India
biospectrumasia
August 01, 2017
2017 has seen a sharp rise in the number of swine flu cases in comparison to 2016.